124 related articles for article (PubMed ID: 25525325)
1. Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases.
Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Munir I; AlAyoubi A
Clin Ophthalmol; 2014; 8():2479-84. PubMed ID: 25525325
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Radioactive Iodine Therapy-Acquired Nasolacrimal Duct Obstruction.
Lee IT; Chen W; Chen Q; Cole HA; Bischoff LA; Jessop AC; Sobel RK
Endocr Pract; 2022 Dec; 28(12):1210-1215. PubMed ID: 35970353
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
Sweeney AR; Davis GE; Chang SH; Amadi AJ
Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
[TBL] [Abstract][Full Text] [Related]
4. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
Fonseca FL; Lunardelli P; Matayoshi S
Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of nasolacrimal duct obstruction after iodine therapy in differentiated thyroid cancer patients.
Li N; Zhang W
Ear Nose Throat J; 2023 Apr; ():1455613231170088. PubMed ID: 37070248
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation.
Van Tassel SH; Segal KL; Hsu NM; Kacker A; Lelli GJ
Orbit; 2017 Apr; 36(2):59-63. PubMed ID: 28388347
[TBL] [Abstract][Full Text] [Related]
7. The Use of Stents in Children with Nasolacrimal Duct Obstruction Requiring Surgical Intervention: A Systematic Review.
Tai ELM; Kueh YC; Abdullah B
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046207
[TBL] [Abstract][Full Text] [Related]
8. Lacrimal sac dacryoliths: predictive factors and clinical characteristics.
Yazici B; Hammad AM; Meyer DR
Ophthalmology; 2001 Jul; 108(7):1308-12. PubMed ID: 11425692
[TBL] [Abstract][Full Text] [Related]
9. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer.
Fard-Esfahani A; Farzanefar S; Fallahi B; Beiki D; Saghari M; Emami-Ardekani A; Majdi M; Eftekhari M
Nucl Med Commun; 2012 Oct; 33(10):1077-80. PubMed ID: 22825036
[TBL] [Abstract][Full Text] [Related]
10. Symptom score questionnaire for nasolacrimal duct obstruction in adults--a novel tool to assess the outcome after endoscopic dacryocystorhinostomy.
Smirnov G; Tuomilehto H; Kokki H; Kemppainen T; Kiviniemi V; Nuutinen J; Kaarniranta K; Seppa J
Rhinology; 2010 Dec; 48(4):446-51. PubMed ID: 21442083
[TBL] [Abstract][Full Text] [Related]
11. External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center.
Ben Simon GJ; Joseph J; Lee S; Schwarcz RM; McCann JD; Goldberg RA
Ophthalmology; 2005 Aug; 112(8):1463-8. PubMed ID: 15953636
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer.
Lee IT; Grice JV; Ji X; Chen Q; Bischoff LA; Jessop AC; Barahimi B; Codere F; Mawn LA; Sobel RK
Thyroid; 2024 Jan; 34(1):82-87. PubMed ID: 37917111
[No Abstract] [Full Text] [Related]
13. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
[TBL] [Abstract][Full Text] [Related]
14. Nasolacrimal duct obstruction secondary to dental impaction.
Giordano Resti A; Bertazzoni G; Trimarchi M
Eur J Ophthalmol; 2014; 24(4):611-3. PubMed ID: 24366764
[TBL] [Abstract][Full Text] [Related]
15. Use of the Masterka for complex nasolacrimal duct obstruction in children.
Khatib L; Nazemzadeh M; Revere K; Katowitz WR; Katowitz JA
J AAPOS; 2017 Oct; 21(5):380-383. PubMed ID: 28917994
[TBL] [Abstract][Full Text] [Related]
16. Indian survey on practice patterns of lacrimal & eyelid disorders (iSUPPLE): Report 3 - Cataract and nasolacrimal duct obstruction.
Nair AG; Kamal S; Agarwal A
Saudi J Ophthalmol; 2017; 31(3):145-149. PubMed ID: 28860911
[TBL] [Abstract][Full Text] [Related]
17. Non-endoscopic endonasal dacryocystorhinostomy--technique, indications, and results.
Razavi ME; Eslampoor A; Noorollahian M; O'Donnell A; Beigi B
Orbit; 2009; 28(1):1-6. PubMed ID: 19229736
[TBL] [Abstract][Full Text] [Related]
18. Nasolacrimal duct obstruction after maxillary orthognathic surgery.
Jang SY; Kim MK; Choi SM; Jang JW
J Oral Maxillofac Surg; 2013 Jun; 71(6):1085-98. PubMed ID: 23385163
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic nasolacrimal duct obstruction after adnexal intervention: An avoidable consequence.
Mukherjee B; Gudkar AI; Nair AG; Poonam NS; Alam MS
Oman J Ophthalmol; 2021; 14(3):157-161. PubMed ID: 34880576
[TBL] [Abstract][Full Text] [Related]
20. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.
Leibovitch I; Selva D; Tsirbas A; Greenrod E; Pater J; Wormald PJ
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1250-4. PubMed ID: 16538447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
